Combination of pembrolizumab and lenvatinib in second-line therapy for MSS/pMMR advanced endometrial cancer: literature review and a case report

Despite the existing standard treatments for endometrial cancer, the prognosis for these patients remained poor until recently. None of currently available cytostatics ensured long-term disease control and long-term survival of patients receiving standard platinum-based therapy. Poor treatment outco...

Full description

Saved in:
Bibliographic Details
Main Authors: A. D. Darenskaya, B. M. Medvedeva, A. A. Rumyantsev
Format: Article
Language:Russian
Published: ABV-press 2024-01-01
Series:Опухоли женской репродуктивной системы
Subjects:
Online Access:https://ojrs.abvpress.ru/ojrs/article/view/1172
Tags: Add Tag
No Tags, Be the first to tag this record!